Management of Pain, Agitation, and Delirium (PAD)

0.0(0)
Studied by 0 people
call kaiCall Kai
Locked
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/17

flashcard set

Earn XP

Description and Tags

Comprehensive vocabulary flashcards covering the assessment and pharmacologic management of pain, agitation, and delirium in the ICU, including sedative and paralytic agents.

Last updated 6:08 PM on 7/4/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

18 Terms

1
New cards

Somatic Pain

Sharp pain or aching caused by the irritation of pain fibers on the body surface or deep tissues.

2
New cards

Visceral Pain

Pressure or squeezing resulting from the stimulation of internal organ pain receptors.

3
New cards

Neuropathic Pain

Burning or tingling caused by an alteration in the peripheral or central nervous system.

4
New cards

Self-reported pain

The gold standard for pain assessment in critically ill patients.

5
New cards

Fentanyl

A mu-opioid receptor agonist characterized by quick onset, short duration, and potential for muscle rigidity.

6
New cards

Naloxone (Narcan)

The reversal agent for opioids.

7
New cards

Ketamine

An N-methyl D-aspartate receptor antagonist that provides analgesic and sedative properties, anti-epileptic activity, and bronchodilation.

8
New cards

Richmond Agitation Sedation Scale (RASS)

A monitoring tool for agitation; light sedation is defined as a score of 00 to 1-1, and deep sedation is defined as 4-4.

9
New cards

Dexmedetomidine (Precedex)

A highly selective alpha-2 agonist in the CNS that has no effect on respiratory drive and is not appropriate for deep sedation.

10
New cards

Propofol

A GABA-A agonist anesthetic formulated in a lipid emulsion that requires the patient to be intubated and has a starting rate of 510mcg/kg/min5-10\,mcg/kg/min.

11
New cards

Propofol Related Infusion Syndrome (PRIS)

A condition characterized by metabolic acidosis, cardiovascular collapse, and hyperkalemia caused by altered hepatic metabolism of lipid emulsion, typically at doses >50mcg/kg/min> 50\,mcg/kg/min.

12
New cards

Benzodiazepines

GABA-B agonists with sedative and amnesic properties that are associated with increased rates of delirium and tachyphylaxis.

13
New cards

Confusion Assessment Method for the ICU (CAM-ICU)

A tool used to assess delirium by monitoring acute change in mental status, inattention, altered level of consciousness, and disorganized thinking.

14
New cards

Haloperidol

A neuroleptic used for delirium; its use carries risks of QT prolongation and extrapyramidal effects.

15
New cards

Modified Ramsay Scale

A clinical scale where a score of 11 indicates an anxious/restless patient and a score of 66 indicates no response to tetanic stimulus.

16
New cards

Succinylcholine

A depolarizing neuromuscular blocking agent (NMBA) with a rapid onset of 30sec30\,\text{sec}, no reversal agent, and a risk of triggering malignant hyperthermia.

17
New cards

Non-depolarizing Paralytics

Agents such as Rocuronium, Vecuronium, Atracurium, and Nimbex that cause skeletal muscle paralysis without altering pain or anxiety.

18
New cards

Romazicon

The reversal agent used for benzodiazepines.